Q2 2025 Fulgent Genetics Inc Earnings Call Transcript

Aug 1, 2025 / 12:30 PM GMT

Release Date Price: €17.3 (+13.07%)

Transcript 10-Q8-K

Key Points

Positve

Fulgent Genetics Inc (FLGT) reported a 16% year-over-year increase in core revenue, reaching $81.7 million.
The company launched a new whole genome sequencing service with enhanced features, improving accuracy and variant calling.
Fulgent Genetics Inc (FLGT) received a CE mark for its Fulgen exome and Fulgen Pipeline Manager, expanding its market reach in Europe.
The company executed over 20 new managed care agreements, adding over 35 million new covered lives to its in-network contracts.
Fulgent Genetics Inc (FLGT) increased its annual revenue guidance for 2025, reflecting strong business performance and growth expectations.

Negative

The company's GAAP loss for the quarter was $19 million, including a one-time non-cash charge related to a $9.9 million impairment.
Operating expenses increased due to higher R&D spending and expanded sales and marketing costs.
The revenue from COVID-19 testing was negligible, indicating a decline in this segment.
Despite the positive revenue growth, the adjusted EBITDA loss for the second quarter was approximately $3 million.
The company anticipates a GAAP EPS loss of $2.10 per share for the full year 2025, reflecting ongoing financial challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FLGT.OQ - Fulgent Genetics Inc
Q2 2025 Fulgent Genetics Inc Earnings Call
Aug 01, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the fold of Genetics Q2 2025 conference call and webcast. At this time, all participants are the only mode. If anyone should require operator assistance, please press 0 on your telephone keypad. A question and answer session will follow the following presentation, and you may be placed into the question queue at any time by pressing 1 on your telephone keypad. As a reminder, this conference is being recorded. It's not my pleasure to introduce your host Lawrence Sloan in investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.